Quotes for Dicot Pharma AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Elin Trampe
Chairperson of the Board
- Eva Sjökvist
Board
- Fredrik Buch
- Jan-Eric Österlund
- Michael Zell
- Mikael von Euler
- Per-Göran Gillberg
Dicot Pharma AB
Dicot Pharma is developing the drug candidate LIB-01, which is expected to be a potency drug to treat erectile dysfunction and premature ejaculation. Duration of action and fewer side effects are main desired properties. Dicot's main strategy is to develop LIB-01 in-house up to and including clinical phase 2a study, and then in partnership with major pharmaceutical companies to finance and further develop LIB-01 into a registered drug for the world market.
News
- Dicot Pharma har skickat in ansökan om start av fas 2a-studie
- Dicot Pharma has submitted clinical trial application for phase 2a trial
- Dicot Pharma har framgångsrikt genomfört ett pre-IND-möte med amerikanska FDA
- Dicot Pharma has successfully completed a pre-IND meeting with FDA
- Förtydligande: Styrelsen i Dicot Pharma avser att besluta om en företrädesemission om cirka 125 miljoner kronor
Videos
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 10,12 | 10,12 | 2024-06-26 |
| Bertil Lindkvist | 8,26 | 8,26 | 2024-06-26 |
| Tore Robertsson | 3,42 | 3,42 | 2024-06-26 |
| Nordnet Pensionsförsäkring | 3,06 | 3,06 | 2024-06-26 |
| Torsten Söderberg med familj | 2,08 | 2,08 | 2024-06-26 |
| Klas Göran Viktor Strömberg | 1,01 | 1,01 | 2024-06-26 |
| Michael Zell | 1,00 | 1,00 | 2024-06-26 |
| Kenneth Sjökvist | 0,83 | 0,83 | 2024-06-26 |
| Swedbank Försäkring | 0,83 | 0,83 | 2024-06-26 |
| Kenth Öhlin | 0,73 | 0,73 | 2024-06-26 |
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.
Insider trading
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority
Key Numbers
*Compiled data from Millistream
Upcoming reports
-
2024-08-01 Delårsrapport Q3 2024
-
2024-08-23 Delårsrapport 2024-Q2
-
2024-10-31 Delårsrapport 2024-Q3
Annual reports, prospectus etc.
- 2024-04-12 Årsredovisning 2023
- 2023-04-28 Årsredovisning 2022
- 2023-01-13 Teaser 2023
- 2023-01-09 Prospekt 2023
- 2022-04-26 Årsredovisning 2021
- 2021-10-12 Teaser 2021
- Show More
- 2021-10-08 Prospekt 2021
- 2021-05-04 Årsredovisning 2020
- 2020-06-05 Prospekt 2020
- 2020-06-05 Teaser 2020
- 2019-09-02 Memorandum 2019
- 2019-04-26 Årsredovisning 2018
- 2018-05-02 Memorandum 2018
- 2018-05-02 Teaser 2018
- 2018-05-02 Teckningssedel 2018
- Close